Study on Clinical Features and Outcomes of Breast Sarcoma
Sponsor: Italian Sarcoma Group · NCT04749446 on ClinicalTrials.gov ↗
Conditions studied
What it tests
- Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments)other
Where it's running14 sites
14 international sites
- Opening soon
Azienda Ospedaliera S. Orsola-Malpighi
Bologna, BO, Italy 40138
- Maria Abbondanza Pantaleo, MD(contact)+39 051 2144043[email protected]
- Maria Abbondanza Pantaleo, MD(principal investigator)
- Opening soon
Istituto Europeo di Oncologia
Milan, MI, Italy 20141
- Tommaso M. De Pas, MD(contact)+390257489482[email protected]
- Tommaso M. De Pas, MD(principal investigator)
- Opening soon
Istituto Clinico Humanitas
Rozzano, MI, Italy 20089
- Alexia Bertuzzi, MD(contact)+390282244540[email protected]
- Alexia Bertuzzi, MD(principal investigator)
- Opening soon
Azienda Ospedaliera Universitaria Paolo Giaccone
Palermo, PA, Italy 90127
- Giuseppe Badalamenti, MD(contact)0039091655[email protected]
- Badalamenti(contact)
- Giuseppe Badalamenti, MD(principal investigator)
- Opening soon
Centro di Riferimento Oncologico - Unit of Medical Oncology
Aviano, Pordenone, Italy 33081
- Angela Buonadonna, MD(contact)[email protected]
- Angela, MD(contact)
- Angela Buonadonna, MD(sub investigator)
- Opening soon
Ospedale Misericordia e Dolce
Prato, PO, Italy 59100
- Giacomo G. Baldi, MD(contact)[email protected]
- Giacomo G. Baldi, MD(principal investigator)
- Opening soon
Policlinico Universitario Campus Biomedico
Roma, RM, Italy 00128
- Bruno Vincenzi, MD(contact)+3902225411123[email protected]
- Bruno Vincenzi, MD(principal investigator)
- Recruiting now
Fondazione del Piemonte per l'Oncologia IRCC Candiolo
Candiolo, Torino, Italy 10060
- Giovanni Grignani, MD(contact)39 (011) 993[email protected]
- Giovanni Grignani, MD(principal investigator)
- Opening soon
Ospedale Umberto I
Turin, TO, Italy
- Nicoletta Biglia(contact)039 0115082[email protected]
- Nicoletta Biglia(principal investigator)
- Opening soon
A.O Ospedali Riuniti Marche Nord
Ancona, Italy
- Raffaella Bracci, MD(contact)039 0721 36[email protected]
- Raffaella Bracci, MD(principal investigator)
- Opening soon
Azienda Ospedaliera Universitaria Careggi
Florence, Italy 50100
- Silvia Gasperoni, MD(contact)39 055 7949648[email protected]
- Silvia Gasperoni, MD(principal investigator)
- Opening soon
Fondazione IRCCS INT Milano
Milan, Italy 20133
- Silvia Stacchiotti, MD(contact)+39022390[email protected]
- Silvia Stacchiotti, MD(principal investigator)
- Opening soon
Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I
Roma, Italy 00144
- Virginia Ferraresi, MD(contact)+390652666[email protected]
- MD(contact)
- Virginia Ferraresi, MD(principal investigator)
- Opening soon
ASL Città di Torino (Dipartimento di Oncologia)
Torino, Italy 10153
- Antonella Boglione, MD(contact)[email protected]
- Boglione, MD(contact)
- Antonella Boglione, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * \>18 years at diagnosis * primary or secondary breast sarcoma * availability of medical data needed for the study (histopathological data, surgery, chemotherapy, including preceding chemotherapeutic regimens for secondary breast sarcomas, radiation therapy) Exclusion Criteria: * sarcoma metastases to the breast * chest wall sarcomas not arising in the mammary gland * cutaneous sarcomas
Updated 2026-01-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.